“Bimekizumab Remission and High Disease Control Over 4 Years in Patients With Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s758, https://doi.org/10.25251/0bnq3318.